TRANSMEDICS PROVIDES ADDITIONAL INFORMATION ON THE IMPACT OF THE RELEASE OF THE VALUATION ALLOWANCE ON DEFERRED TAX ASSETS ON PREVIOUSLY REPORTED FOURTH QUARTER FINANCIAL RESULTS
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.